The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
oleh: Wittkowski H, Kuemmerle-Deschner JB, Gramlich K, Tzaribachev N, Felix SD, Jung T, Roth J, Rordorf C, Foell D
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2008-09-01 |
Deskripsi
No description available for this item.